CTOs on the Move

Truesec

www.truesec.com

 
TrueSec is a cybersecurity company that offers consulting services, hands-on training, and workshops to help organizations prevent cyber breaches and minimize their impact. They specialize in incident response, threat intelligence, and legal requirements.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

The Construction Link

The Construction Link is a Geneva, NY-based company in the Software and Internet sector.

Blinker

Blinker is a free mobile app that empowers people to buy, sell, finance and refinance cars themselves with the snap of a photo. Using patented image-recognition technology, Blinker makes it quick, easy and safe to buy and sell without middlemen. Founded in 2013, Blinker is headquartered in Denver and is led by a team of auto and finance industry veterans.

IntelliKid Systems

IntelliKid Systems is a company that provides a suite of tools aimed at helping child care centers increase enrollment. Their tools allow centers to capture, organize, communicate, engage, and analyze families that want to become a part of their program.

Judy Sunblade

I demystify sales and marketing for businesses and entrepreneurs to ignite revenue and profits.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.